Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
GRACE has partnered with Lilly Oncology again this year for the REThink Testing Campaign
for Lung Cancer Awareness Month
Comprehensive Biomarker Testing
While 3-4 weeks can seem like a long time after a cancer diagnosis, It's worth the wait to understand your specific cancer type and the genes that drive it. As more targeted treatments become available through clinical trials and FDA Approvals, there is hope for more personalized medicines that specifically target your cancer.
For Lung Cancer Awareness Month, we have again partnered with Lilly Oncology to help spread the word and education about biomarker testing, and the important role it plays in ensuring that a patient gets matched to the right treatment at the right time.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's beautiful Linda. Thank you,